These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2178384)

  • 21. Captopril improves hemodynamic response to static exercise in patients with congestive heart failure: a double-blind, placebo-controlled, randomized trial.
    Borgi C; Magelli C; Costa FV; Magnani B; Ambrosioni E
    Clin Cardiol; 1990 May; 13(5):329-34. PubMed ID: 2189613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    Am J Cardiol; 1987 Aug; 60(5):68C-71C. PubMed ID: 2956872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects.
    Lang CC; Stein CM; He HB; Wood AJ
    Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure.
    Packer M
    Am J Cardiol; 1989 Jan; 63(2):41A-45A. PubMed ID: 2642629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of treatment with captopril on exercise tolerance and plasma catecholamines in elderly hypertensives.
    Kusaka M; Atarashi K; Matsumoto K; Sumida Y; Shingu T; Ootsuki T; Matsuura H; Kajiyama G
    J Hypertens Suppl; 1989 Sep; 7(7):S59-61. PubMed ID: 2693659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
    Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
    N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of milrinone on ventricular arrhythmias in congestive heart failure.
    Ferrick KJ; Fein SA; Ferrick AM; Doyle JT
    Am J Cardiol; 1990 Aug; 66(4):431-4. PubMed ID: 2386119
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of captopril on the exercise performance in patients with congestive heart failure].
    Han YL; Tong M; Miao ZL
    Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):281-3, 317. PubMed ID: 1478125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic alterations after sodium restriction and short-term captopril administration.
    Mills PJ; Dimsdale JE; Ziegler MG; Hauger RL; Nelesen RA; Brown MR
    J Am Coll Cardiol; 1993 Jan; 21(1):177-81. PubMed ID: 8380185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic effects of milrinone on patients with chronic congestive heart failure: a multicenter study. Cooperative Group for Phase II Clinical Trial of Milrinone].
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):599-602. PubMed ID: 8697925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
    Liu L; Zhao SP
    Int J Cardiol; 1999 Apr; 69(1):77-82. PubMed ID: 10362376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
    Cardiology; 1995; 86 Suppl 1():34-40. PubMed ID: 7614505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic achievements of phosphodiesterase inhibitors and the future.
    Jewitt DE
    Eur Heart J; 1989 Aug; 10 Suppl C():53-9. PubMed ID: 2680498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
    Thackray S; Witte K; Clark AL; Cleland JG
    Eur J Heart Fail; 2000 Jun; 2(2):209-12. PubMed ID: 10856736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Milrinone, a bridge to heart transplantation.
    Watson DM; Sherry KM; Weston GA
    Anaesthesia; 1991 Apr; 46(4):285-7. PubMed ID: 2024747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial.
    Boccanelli A; Zachara E; Liberatore SM; Carboni GP; Prati PL
    Postgrad Med J; 1986; 62 Suppl 1():184-7. PubMed ID: 3534859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
    Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
    Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.